Similar articles

• Pharmacokinetics and bioavailability of alclofenac and its lysine-salt after different route of administration in the rabbit.

  Testa R, Airoldi L, Latini R. Testa R, et al. Pharmacol Res Commun. 1978 Jan;10(1):53-63. doi: 10.1016/s0031-6989(78)80062-9. Pharmacol Res Commun. 1978. PMID: 25443 No abstract available.
• Impact of pharmaceutical dosage forms on the pharmacokinetics of roxithromycin in healthy human volunteers.

  Sun J, Zhang T, Qiu F, Liu Y, Tang J, Huang H, He Z. Sun J, et al. J Antimicrob Chemother. 2005 May;55(5):796-9. doi: 10.1093/jac/dki082. Epub 2005 Mar 10. J Antimicrob Chemother. 2005. PMID: 15761061
• Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol).

  Kendall MJ, Thornhill DP, Willis JV. Kendall MJ, et al. Rheumatol Rehabil. 1979;Suppl 2:38-46. Rheumatol Rehabil. 1979. PMID: 531447
• A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.

  Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L. Marcelín-Jiménez G, et al. Clin Ther. 2009 Sep;31(9):2002-11. doi: 10.1016/j.clinthera.2009.09.016. Clin Ther. 2009. PMID: 19843490 Clinical Trial.
• Therapeutic inequivalence of pharmaceutical alternates.

  Levy RA. Levy RA. Am Pharm. 1985 Apr;NS25(4):28-39. Am Pharm. 1985. PMID: 3893084 Review. No abstract available.